Nearly three-quarters of older adults with advanced cancer value quality of life over extending survival, according to study ...

At two doses, baxdrostat demonstrated significant reduction in mean seated systolic BP vs. placebo at 12 weeks among patients with uncontrolled or treatment-resistant hypertension, AstraZeneca ...